Treatment of a human glioblastoma cell line with IFN-alpha induced a 5-fold increase in ADAR1a, which was accompanied by significant changes in the editing of serotonin 2C receptor (5HT2CR) mRNA61. The gene discussed is HTR2C; the disease is glioblastoma.